Home Cart Sign in  
Chemical Structure| 33252-64-1 Chemical Structure| 33252-64-1

Structure of 33252-64-1

Chemical Structure| 33252-64-1

3-Nitro-5-(trifluoromethyl)pyridin-2(1H)-one

CAS No.: 33252-64-1

4.5 *For Research Use Only !

Cat. No.: A107577 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łÇò¶ÊÊ Inquiry Inquiry
1g łËʶÊÊ Inquiry Inquiry
5g łÍÿ¶ÊÊ Inquiry Inquiry
10g łóď¶ÊÊ Inquiry Inquiry
25g łÇîʶÊÊ Inquiry Inquiry
100g łòóò¶ÊÊ Inquiry Inquiry
500g ł§Êʧ¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 250mg

    łÇò¶ÊÊ

  • 1g

    łËʶÊÊ

  • 5g

    łÍÿ¶ÊÊ

  • 10g

    łóď¶ÊÊ

  • 25g

    łÇîʶÊÊ

  • 100g

    łòóò¶ÊÊ

  • 500g

    ł§Êʧ¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 33252-64-1 ]

CAS No. :33252-64-1
Formula : C6H3F3N2O3
M.W : 208.09
SMILES Code : O=C1C([N+]([O-])=O)=CC(C(F)(F)F)=CN1
MDL No. :MFCD00153193
InChI Key :JYXKHKBZLLIWEV-UHFFFAOYSA-N
Pubchem ID :2775093

Safety of [ 33252-64-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Computational Chemistry of [ 33252-64-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 14
Num. arom. heavy atoms 6
Fraction Csp3 0.17
Num. rotatable bonds 2
Num. H-bond acceptors 6.0
Num. H-bond donors 1.0
Molar Refractivity 40.89
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

78.68 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.57
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.68
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.45
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.28
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.48
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.89

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.74
Solubility 3.75 mg/ml ; 0.018 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.91
Solubility 2.57 mg/ml ; 0.0123 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.21
Solubility 1.29 mg/ml ; 0.00622 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.09 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.09

Application In Synthesis of [ 33252-64-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 33252-64-1 ]

[ 33252-64-1 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 33252-64-1 ]
  • [ 129931-47-1 ]
  • 1-(2-Chloro-6-cyano-4-trifluoromethylphenyl)-3-nitro-5-trifluoromethyl-2-pyridone [ No CAS ]
YieldReaction ConditionsOperation in experiment
(h) 1-(2-Chloro-6-cyano-4-trifluoromethylphenyl)-3-nitro-5-trifluoromethyl-2-pyridone (Compound No 15 in Table II) was prepared by the reaction of 3-chloro-4-fluoro-5-cyanotrifluoromethylbenzene and 3-nitro-5-trifluoromethyl-2-pyridone. 1 H NMR delta(CDCl3): 8.65 (1H,d); 8.17 (1H,d); 8.08 (1H,d); 7.89 (1H,m).
  • 2
  • [ 33252-64-1 ]
  • [ 1214336-90-9 ]
YieldReaction ConditionsOperation in experiment
Intermediate A1: 2-Bromo-3-nitro-5-trifluoromethyl-pyridine3-Nitro-5-(trifluoromethyl)pyridin-2-ol (31.00 g, 149 mmol) was dissolved in acetonitrile (250 ml) to give a dark brown solution. Phosphorus(V) oxybromide (85 g, 298 mmol) was added and the mixture was heated at reflux for 4.5 hours and then stirred at RT overnight. The reaction mixture was quenched by pouring into vigorously stirring water (600 ml) containing sodium hydrogencarbonate (110 g). The dark brown mixture was extracted with DCM (3×200 ml) and the organic phase was washed with water (200 ml) and brine (100 ml), dried (MgSO4) and concentrated in vacuo to afford the title product as a brown oil. 1H-NMR: [400 MHz, CDCl3, deltaH, 8.87 (1H, d, J=1.4 Hz, ArH), 8.39 (1H, d, J=1.9 Hz, ArH).
With phosphorus(V) oxybromide; In acetonitrile; at 20.0℃;Reflux; 3-Nitro-5-(trifluoromethyl)pyridin-2-ol (31.00 g, 149 mmol) was dissolved in acetonitrile (250 ml) to give a dark brown solution. Phosphorus(V) oxybromide (85 g, 298 mmol) was added and the mixture was heated at reflux for 4 hours and then stirred at RT overnight. The reaction mixture was quenched by pouring into vigorously stirring water (600 ml) containing sodium hydrogencarbonate (1 10 g). The dark brown mixture was extracted with DCM (3 x 200 ml) and the organic phase was washed with water (200 ml) and brine (100ml), dried (MgS04) and concentrated in vacuo to afford the title product as a brown oil. H-NMR: [400MHz, CDCI3, ? 8.87 (1 H, d, J = 1.4Hz, ArH), 8.39 (1 H, d, J = 1.9Hz, ArH).
With phosphorus(V) oxybromide; In acetonitrile; at 20.0℃;Reflux; 3-Nitro-5-(trifluoromethyl)pyridin-2-ol (31.00 g, 149 mmol) was dissolved in acetonitrile (250 ml) to give a dark brown solution. Phosphorus(V) oxybromide (85 g, 298 mmol) was added and the mixture was heated at reflux for 4 hours and then stirred at RT overnight. The reaction mixture was quenched by pouring into vigorously stirring water (600 ml) containing sodium hydrogencarbonate (1 10 g). The dark brown mixture was extracted with DCM (3 x 200 ml) and the organic phase was washed with water (200 ml) and brine (100ml), dried (MgS04) and concentrated under reduced pressure to afford the title product as a brown oil. H-NMR: [400MHz, CDCI3, ? 8.87 (1 H, d, J = 1.4Hz, ArH), 8.39 (1 H, d, J = 1 .9Hz, ArH).
With phosphorus(V) oxybromide; In acetonitrile; at 20.0℃;Reflux; 3-Nitro-5-(trifluoromethyl)pyridin-2-ol (31.00 g, 149 mmol) was dissolved in acetonitrile (250 ml) to give a dark brown solution. Phosphorus(V) oxybromide (85 g, 298 mmol) was added and the mixture was heated at reflux for 4 hours and then stirred at RT overnight. The reaction mixture was quenched by pouring into vigorously stirring water (600 ml) containing sodium hydrogencarbonate (1 10 g). The dark brown mixture was extracted with DCM (3 x 200 ml) and the organic phase was washed with water (200 ml) and brine (100ml), dried (MgS04) and concentrated under reduced pressure to afford the title product as a brown oil. H-NMR: [400MHz, CDCI3, ? 8.87 (1 H, d, J = 1.4Hz, ArH), 8.39 (1 H, d, J = 1 .9Hz, ArH).
With phosphorus(V) oxybromide; at 20.0℃;Reflux; 3-Nitro-5-(trifluoromethyl)pyridin-2-ol (31.00 g, 149 mmol) was dissolved in acetonitrile (250 ml) to give a dark brown solution. Phosphorus(V) oxybromide (85 g, 298 mmol) was added and the mixture was heated at reflux for 4 hours and then stirred at RT overnight. The reaction mixture was quenched by pouring into vigorously stirring water (600 ml) containing sodium hydrogencarbonate (1 10 g). The dark brown mixture was extracted with DCM (3 x 200 ml) and the organic phase was washed with water (200 ml) and brine (100ml), dried (MgS04) and concentrated under reduced pressure to afford the title product as a brown oil. H-NMR: [400MHz, CDCI3, ? 8.87 (1 H, d, J = 1.4Hz, ArH), 8.39 (1 H, d, J = 1.9Hz, ArH).
With phosphorus(V) oxybromide; In acetonitrile; at 20.0℃;Reflux; 3-Nitro-5-(trifluoromethyl)pyridin-2-ol (31 .00 g, 149 mmol) was dissolved in acetonitrile (250 ml) to give a dark brown solution. Phosphorus(V) oxybromide (85 g, 298 mmol) was added and the mixture was heated at reflux for 4 hours and then stirred at RT overnight. The reaction mixture was quenched by pouring into vigorously stirring water (600 ml) containing sodium hydrogencarbonate (1 10g). The dark brown mixture was extracted with DCM (3 x 200 ml) and the organic phase was washed with water (200 ml) and brine (100 ml), dried ( MgS04) and concentrated in vacuo to afford the title product as a brown oil. 1H-NMR: [400MHz, CDCI3, deltaEta 8.87 (1 H, d, J = 1.4Hz, ArH), 8.39 (1 H, d, J = 1.9Hz, ArH).
2.44g With phosphorus(V) oxybromide; In acetonitrile; for 16.0h;Reflux; The 3-nitro-5-trifluoro-Methylpyridin-2-ol (q) (3.12g, 15mmol) in acetonitrile (25 ml) was added to solution POBr 3 (8.6g, 30mmol). Refluxed for 4 hours after stirring at room temperature for 12 hours. The reaction solution is poured into the rapidly stirred sodium bicarbonate (11g) aqueous solution (60 ml). Extraction with methylene chloride mixture (3x20ml), organic phase water (20 ml) and saturated sodium chloride solution (10 ml) after washing, drying by anhydrous sodium sulfate, concentrated to obtain the product (r) (2.44g, 9 . 0mmol)

 

Historical Records

Categories

Related Functional Groups of
[ 33252-64-1 ]

Fluorinated Building Blocks

Chemical Structure| 386-71-0

A147894 [386-71-0]

2-Nitro-3-(trifluoromethyl)aniline

Similarity: 0.72

Chemical Structure| 393-12-4

A720567 [393-12-4]

N-(4-Nitro-3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.71

Chemical Structure| 136888-20-5

A151859 [136888-20-5]

5-Fluoro-3-nitropyridin-2(1H)-one

Similarity: 0.71

Chemical Structure| 883028-23-7

A173947 [883028-23-7]

N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzamide

Similarity: 0.69

Chemical Structure| 22123-19-9

A122580 [22123-19-9]

6-Methyl-4-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.68

Amides

Chemical Structure| 21901-18-8

A115913 [21901-18-8]

4-Methyl-3-nitropyridin-2(1H)-one

Similarity: 0.78

Chemical Structure| 393-12-4

A720567 [393-12-4]

N-(4-Nitro-3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.71

Chemical Structure| 136888-20-5

A151859 [136888-20-5]

5-Fluoro-3-nitropyridin-2(1H)-one

Similarity: 0.71

Chemical Structure| 6332-56-5

A127229 [6332-56-5]

3-Nitropyridin-2(1H)-one

Similarity: 0.70

Chemical Structure| 228410-90-0

A314414 [228410-90-0]

5-bromo-2-hydroxy-3-nitro-4-picoline

Similarity: 0.70

Nitroes

Chemical Structure| 21901-18-8

A115913 [21901-18-8]

4-Methyl-3-nitropyridin-2(1H)-one

Similarity: 0.78

Chemical Structure| 386-71-0

A147894 [386-71-0]

2-Nitro-3-(trifluoromethyl)aniline

Similarity: 0.72

Chemical Structure| 393-12-4

A720567 [393-12-4]

N-(4-Nitro-3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.71

Chemical Structure| 136888-20-5

A151859 [136888-20-5]

5-Fluoro-3-nitropyridin-2(1H)-one

Similarity: 0.71

Chemical Structure| 6332-56-5

A127229 [6332-56-5]

3-Nitropyridin-2(1H)-one

Similarity: 0.70

Trifluoromethyls

Chemical Structure| 386-71-0

A147894 [386-71-0]

2-Nitro-3-(trifluoromethyl)aniline

Similarity: 0.72

Chemical Structure| 393-12-4

A720567 [393-12-4]

N-(4-Nitro-3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.71

Chemical Structure| 883028-23-7

A173947 [883028-23-7]

N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzamide

Similarity: 0.69

Chemical Structure| 22123-19-9

A122580 [22123-19-9]

6-Methyl-4-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.68

Chemical Structure| 393-11-3

A143540 [393-11-3]

4-Nitro-3-(trifluoromethyl)aniline

Similarity: 0.68

Related Parent Nucleus of
[ 33252-64-1 ]

Pyridines

Chemical Structure| 21901-18-8

A115913 [21901-18-8]

4-Methyl-3-nitropyridin-2(1H)-one

Similarity: 0.78

Chemical Structure| 136888-20-5

A151859 [136888-20-5]

5-Fluoro-3-nitropyridin-2(1H)-one

Similarity: 0.71

Chemical Structure| 6332-56-5

A127229 [6332-56-5]

3-Nitropyridin-2(1H)-one

Similarity: 0.70

Chemical Structure| 228410-90-0

A314414 [228410-90-0]

5-bromo-2-hydroxy-3-nitro-4-picoline

Similarity: 0.70

Chemical Structure| 22123-19-9

A122580 [22123-19-9]

6-Methyl-4-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.68